Blogs

GLP-1 demand is going to remain higher than supply for foreseeable future, says BMO's Evan Seigerman

Evan Seigerman, BMO senior analyst, joins 'Closing Bell Overtime' to talk today's Capitol Hill hearing with Novo Nordisk's CEO and the demand for weight-loss drugs.

Sep 24, 2024 | Health

Evan Seigerman, BMO senior analyst, joins 'Closing Bell Overtime' to talk today's Capitol Hill hearing with Novo Nordisk's CEO and the demand for weight-loss drugs..

Back to Health Page

GLP-1 demand is going to remain higher than supply for foreseeable future, says BMO's Evan Seigerman

How To Prevent Pancreatic Cancer? Early Detection and Genetic Risks Key to Better Outcomes

Amneal files again for FDA approval of first dihydroergotamine autoinjector

Short-term menopausal hormone therapy shows no long-term cognitive effects

Restaurant review: I didn’t think a beer-paired dinner was for me – but this tasting menu is a triumph

‘Do not travel’ warning as London Gatwick Airport evacuated due to ‘police incident’

Need extra support? Get 30% off Brooklyn Bedding's Titan Plus mattress in huge Black Friday sale

Senior managers at Hong Kong public hospitals may be held responsible for blunders

Cetuximab performs better than durvalumab in treating head and neck cancers

Get the FASHION, BEAUTY, ENTERTAINMENT, FOOD
and more

NEWSLETTER SUBSCRIPTION

GLP-1 demand is going to remain higher than supply for foreseeable future, says BMO's Evan Seigerman

Get the FASHION, BEAUTY, ENTERTAINMENT, FOOD and more

Get the FASHION, BEAUTY, ENTERTAINMENT, FOOD
and more